Alamar Biosciences Unveils NULISAseq Inflammation Panel AQ
Revolutionary tool enables comprehensive quantitation of immune response in clinical cohorts. Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announce the launch of the NULISAseq™ Inflammation Panel AQ, setting a new standard in profiling the immune response in clinical or longitudinal studies. Designed to deliver unparalleled […]